MENU
+Compare
LMAT
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$84.34
Change
+$0.37 (+0.44%)
Capitalization
1.91B

LMAT LeMaitre Vascular Forecast, Technical & Fundamental Analysis

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease... Show more

LMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LMAT with price predictions
Dec 24, 2025

LMAT sees its Stochastic Oscillator ascends from oversold territory

On December 11, 2025, the Stochastic Oscillator for LMAT moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 19, 2025. You may want to consider a long position or call options on LMAT as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LMAT just turned positive on December 12, 2025. Looking at past instances where LMAT's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LMAT advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.051) is normal, around the industry mean (9.534). P/E Ratio (36.353) is within average values for comparable stocks, (167.335). Projected Growth (PEG Ratio) (1.826) is also within normal values, averaging (2.546). Dividend Yield (0.009) settles around the average of (0.017) among similar stocks. P/S Ratio (8.026) is also within normal values, averaging (112.419).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LMAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LMAT is expected to report earnings to rise 6.77% to 66 cents per share on February 19

LeMaitre Vascular LMAT Stock Earnings Reports
Q4'25
Est.
$0.66
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of 62 cents, beating the estimate of 56 cents. With 56.89K shares outstanding, the current market capitalization sits at 1.91B.
A.I.Advisor
published Dividends

LMAT paid dividends on September 04, 2025

LeMaitre Vascular LMAT Stock Dividends
А dividend of $0.20 per share was paid with a record date of September 04, 2025, and an ex-dividend date of August 21, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of vascular devices for vascular surgeons

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
63 Second Avenue
Phone
+1 781 221-2266
Employees
630
Web
https://www.lemaitre.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DGEAX25.200.09
+0.36%
BNY Mellon Global Emerging Mkts - A
STFAX522.511.67
+0.32%
State Street Equity 500 Index Adm
FSGRX23.540.06
+0.26%
Franklin Small Cap Growth A
JEASX17.730.04
+0.23%
Janus Henderson Global Sust Eq A
BUFIX23.860.04
+0.17%
Buffalo International

LMAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
-0.64%
ITGR - LMAT
48%
Loosely correlated
-1.84%
SYK - LMAT
46%
Loosely correlated
-0.48%
UFPT - LMAT
44%
Loosely correlated
+1.31%
SOLV - LMAT
42%
Loosely correlated
-0.28%
AORT - LMAT
40%
Loosely correlated
+0.66%
More

Groups containing LMAT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
-0.64%
Pharmaceuticals: Other
industry (102 stocks)
38%
Loosely correlated
+0.21%
Pharmaceuticals
industry (375 stocks)
30%
Poorly correlated
+0.29%